A nurse is caring for an adult client in a provider's office. Complete the diagram by dragging from the choices below to specify what condition the client is most likely experiencing, 2 actions the nurse should take to address that condition, and 2 parameters the nurse should monitor to assess the client's progress.

Rationale for correct condition Grouped vesicles on an erythematous base along a dermatomal distribution with burning pain are classic for herpes zoster. Normal x-ray excludes musculoskeletal injury. Normal vitals exclude systemic infection. The pain pattern and vesicular rash confirm shingles rather than dermatitis or cellulitis. Herpes zoster is caused by reactivation of varicella-zoster virus in dorsal root ganglia. The dermatomal rash and neuropathic pain are hallmark features. Ibuprofen is ineffective because pain is neuropathic. The absence of systemic signs rules out cellulitis. Distribution excludes herpes simplex virus type 2. Rationale for correct actions Antiviral therapy reduces viral replication, shortens disease course, and lowers risk of post-herpetic neuralgia. Monitoring for neuralgia is essential because nerve damage can persist after rash resolution. Both actions directly address the viral etiology and neuropathic complications of herpes zoster. Requesting antiviral medication such as acyclovir or valacyclovir decreases viral shedding and accelerates lesion healing. Early initiation within 72 hours reduces severity and duration of pain. Antivirals also lower risk of secondary bacterial infection. Monitoring for post-herpetic neuralgia is critical because persistent neuropathic pain occurs in up to 20% of patients. Neuralgia results from nerve fiber damage by viral inflammation. Early detection allows initiation of neuropathic pain management such as gabapentin. Rationale for correct parameters Pain monitoring assesses severity of neuropathic involvement and guides analgesic therapy. Monitoring broken skin areas prevents secondary bacterial infection. Both parameters are directly linked to herpes zoster complications and ensure effective symptom management and prevention of further morbidity. Pain assessment is essential because herpes zoster causes severe neuropathic pain resistant to NSAIDs. Tracking pain intensity guides use of antivirals and adjuvant analgesics. Persistent pain may indicate post-herpetic neuralgia. Broken skin areas must be monitored because vesicles rupture, creating portals for bacterial entry. Secondary infection can complicate healing and increase morbidity. Observation ensures timely wound care and infection prevention. Rationale for incorrect conditions Atopic dermatitis presents with pruritus and flexural distribution, not dermatomal vesicles. Cellulitis causes diffuse erythema, warmth, and systemic signs, not grouped vesicles. Herpes simplex virus type 2 affects genitalia, not shoulder dermatomes. Each lacks the hallmark dermatomal vesicular rash seen here. Atopic dermatitis is ruled out because lesions are pruritic, chronic, and flexural, not acute dermatomal vesicles. Cellulitis is ruled out because there is no fever, leukocytosis, or diffuse erythema. Herpes simplex virus type 2 is ruled out because lesions are genital, not thoracic dermatomal. Rationale for incorrect actions Topical corticosteroids are used for dermatitis, not viral infections. Safe-sex practices apply to herpes simplex virus type 2, not shingles. IV antibiotics are indicated for cellulitis, not herpes zoster. These actions do not address viral replication or neuropathic pain. Topical corticosteroids reduce inflammation in dermatitis but worsen viral infections. Safe-sex practices prevent HSV-2 transmission but are irrelevant to shingles, which spreads via respiratory droplets or direct contact. IV antibiotics treat bacterial cellulitis but have no effect on varicella-zoster virus. Rationale for incorrect parameters Vesicles on genitalia are monitored in HSV-2, not shingles. Pruritus on hands, elbows, and neck is monitored in atopic dermatitis, not shingles. Widespread urination changes are irrelevant. Only pain and broken skin are clinically significant in herpes zoster. Vesicles on genitalia indicate HSV-2 infection, not shingles. Pruritus on flexural areas indicates dermatitis, not shingles. Urination changes are unrelated to herpes zoster pathophysiology. Test-taking strategy Identify hallmark features Dermatomal vesicles and burning neuropathic pain point to herpes zoster. Rule out musculoskeletal causes Normal x-ray excludes fracture or dislocation. Match interventions to etiology Antivirals treat viral replication; neuralgia monitoring addresses complications. Eliminate distractors Corticosteroids apply to dermatitis, antibiotics to cellulitis, safe-sex to HSV-2. Match parameters to complications Pain and broken skin are directly linked to shingles outcomes. Focus on safety Prevent secondary infection and manage neuropathic pain to reduce morbidity. Take home points Shingles presents with dermatomal vesicles and neuropathic pain. Antivirals reduce severity and prevent complications. Pain and skin integrity monitoring are essential. Differentiate shingles from dermatitis, cellulitis, and HSV-2 based on lesion distribution and systemic signs.